Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Expanding the boundaries of harm reduction: Why anabolic-androgenic steroid users require a paradigm shift

AI Summary
  • AAS users differ in motivations and patterns, requiring distinct harm reduction frameworks.
  • Current services fail to offer medical monitoring, credible information and non-judgemental access, perpetuating harms and user disengagement.
  • A paradigm shift should integrate clinical care, peer-led outreach, policy reform and decriminalisation to reduce harms and stigma.
Summarise with AI (MRCPsych/FRANZCP)

Addiction. 2026 Jul 30. doi: 10.1111/add.70564. Online ahead of print.

NO ABSTRACT

PMID:42533255 | DOI:10.1111/add.70564

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD